Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study)

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure

(2011) K. Rychli et al.   HEART

Hepatocyte growth factor twenty years on: Much more than a growth factor

(2011) Takahiro Nakamura et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Usefulness of Serial Assessment of B-Type Natriuretic Peptide, Troponin I, and C-Reactive Protein to Predict Left Ventricular Remodeling After Acute Myocardial Infarction (from the REVE-2 Study)

(2010) Marie Fertin et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cardiac remodelling and myocardial recovery: lost in translation?

(2010) Douglas L. Mann et al.   EUROPEAN JOURNAL OF HEART FAILURE

Proteomic analysis of myocardial tissue from the border zone during early stage post-infarct remodelling in rats

(2010) Fei Xiang et al.   EUROPEAN JOURNAL OF HEART FAILURE

Fixed-Dose Telmisartan/Hydrochlorothiazide in Comparison With Losartan/Hydrochlorothiazide in Decreasing Serum Hepatocyte Growth Factor and Improving Endothelial Dysfunction in Hypertensive Patients

(2010) Ze-Ping Hu et al.   International Heart Journal

Hepatocyte Growth Factor Modulates Interleukin-6 Production in Bone Marrow Derived Macrophages: Implications for Inflammatory Mediated Diseases

(2010) Gina M. Coudriet et al.   PLoS One

Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction

(2010) Marie Fertin et al.   Proteomics Clinical Applications

The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction

(2008) P. V. Ennezat et al.   EUROPEAN HEART JOURNAL